Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Still in the news: vasopeptidase inhibitor omapatrilat a protagonist in Barcelona

Aug. 30, 1999

The aging heart: Should we refine management?

Aug. 27, 1999

Cardioselective potassium channel blocker advances to phase II trials at HMR

Aug. 25, 1999

FDA approves phase III protocol for Cypros' Cordox

Aug. 25, 1999

Tezosentan, a novel ETA/ETB antagonist for parenteral treatment of acute hemodynamic conditions

Aug. 24, 1999

Selective endothelin ETB receptor antagonists disclosed by Shionogi

Aug. 24, 1999

Academic team identifies novel modulators of cholinergic function

Aug. 23, 1999

ICAgen researchers patent new potassium channel blockers

Aug. 23, 1999

WHI-P164, a potential treatment for atherosclerosis in patients with hyperlipidemia, hypertension

Aug. 23, 1999

CV Therapeutics reports initial results from ranolazine trial

Aug. 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026